共 128 条
[1]
Bjerregaard NC(2007)Diagnostic value of self-reported symptoms in Danish outpatients referred with symptoms consistent with colorectal cancer Colorectal Dis 9 443-51
[2]
Tottrup A(1993)Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study N Engl J Med 328 1365-71
[3]
Sorensen HT(2013)Survival outcome of patients with screening versus symptomatically detected colorectal cancers Colorectal Dis 15 74-9
[4]
Laurberg S(2014)Blood-based testing for colorectal cancer screening Mol Diagn Ther 18 127-35
[5]
Mandel JS(2011)Screening for colorectal cancer: possible improvements by risk assessment evaluation? Scand J Gastroenterol 46 1283-94
[6]
Bond JH(2005)AGA Future Trends Committee report: Colorectal cancer: a qualitative review of emerging screening and diagnostic technologies Gastroenterology 129 1083-103
[7]
Church TR(2013)Colorectal cancer screening with blood-based biomarkers: cost-effectiveness of methylated septin 9 DNA versus current strategies Cancer Epidemiol Biomarkers Prev 22 1567-76
[8]
Snover DC(2009)Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer Clin Chem 55 1337-46
[9]
Bradley GM(2014)Plasma Septin9 versus fecal immunochemical testing for colorectal cancer screening: a prospective multicenter study PLoS One 9 414-23
[10]
Schuman LM(2008)DNA methylation biomarkers for blood-based colorectal cancer screening Clin Chem 54 317-25